Comparison of minocycline susceptibility testing methods for carbapenem-resistant acinetobacter baumannii

Peng Wang, Sarah L. Bowler, Serena F. Kantz, Roberta T. Mettus, Yan Guo, Christi L. McElheny, Yohei Doi

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Treatment options for infections due to carbapenem-resistant Acinetobacter baumannii are extremely limited. Minocycline is a semisynthetic tetracycline derivative with activity against this pathogen. This study compared susceptibility testing methods that are used in clinical microbiology laboratories (Etest, disk diffusion, and Sensititre broth microdilution methods) for testing of minocycline, tigecycline, and doxycycline against 107 carbapenem-resistant A. baumannii clinical isolates. Susceptibility rates determined with the standard broth microdilution method using cation-adjusted Mueller-Hinton (MH) broth were 77.6% for minocycline and 29% for doxycycline, and 92.5% of isolates had tigecycline MICs of ≤2 μg/ml. UsingMHagar from BD and Oxoid, susceptibility rates determined with the Etest method were 67.3% and 52.3% for minocycline, 21.5% and 18.7% for doxycycline, and 71% and 29.9% for tigecycline, respectively. With the disk diffusion method usingMHagar from BD and Oxoid, susceptibility rates were 82.2% and 72.9% for minocycline and 34.6% and 34.6% for doxycycline, respectively, and rates of MICs of ≤2 μg/ml were 46.7% and 23.4% for tigecycline. In comparison with the standard broth microdilution results, very major rates were low (∼2.8%) for all three drugs across the methods, but major error rates were higher (∼5.6%), especially with the Etest method. For minocycline, minor error rates ranged from 14% to 37.4%. For tigecycline, minor error rates ranged from 6.5% to 69.2%. The majority of minor errors were due to susceptible results being reported as intermediate. For minocycline susceptibility testing of carbapenem-resistant A. baumannii strains, very major errors are rare, but major and minor errors overcalling strains as intermediate or resistant occur frequently with susceptibility testing methods that are feasible in clinical laboratories.

Original languageEnglish
Pages (from-to)2937-2941
Number of pages5
JournalJournal of clinical microbiology
Volume54
Issue number12
DOIs
Publication statusPublished - 01-12-2016

Fingerprint

Acinetobacter baumannii
Minocycline
Carbapenems
Disk Diffusion Antimicrobial Tests
Doxycycline
Microbiology
Tetracycline
Cations
tigecycline

All Science Journal Classification (ASJC) codes

  • Microbiology (medical)

Cite this

Wang, Peng ; Bowler, Sarah L. ; Kantz, Serena F. ; Mettus, Roberta T. ; Guo, Yan ; McElheny, Christi L. ; Doi, Yohei. / Comparison of minocycline susceptibility testing methods for carbapenem-resistant acinetobacter baumannii. In: Journal of clinical microbiology. 2016 ; Vol. 54, No. 12. pp. 2937-2941.
@article{1f09c80655c944d59bbf00c2cad27042,
title = "Comparison of minocycline susceptibility testing methods for carbapenem-resistant acinetobacter baumannii",
abstract = "Treatment options for infections due to carbapenem-resistant Acinetobacter baumannii are extremely limited. Minocycline is a semisynthetic tetracycline derivative with activity against this pathogen. This study compared susceptibility testing methods that are used in clinical microbiology laboratories (Etest, disk diffusion, and Sensititre broth microdilution methods) for testing of minocycline, tigecycline, and doxycycline against 107 carbapenem-resistant A. baumannii clinical isolates. Susceptibility rates determined with the standard broth microdilution method using cation-adjusted Mueller-Hinton (MH) broth were 77.6{\%} for minocycline and 29{\%} for doxycycline, and 92.5{\%} of isolates had tigecycline MICs of ≤2 μg/ml. UsingMHagar from BD and Oxoid, susceptibility rates determined with the Etest method were 67.3{\%} and 52.3{\%} for minocycline, 21.5{\%} and 18.7{\%} for doxycycline, and 71{\%} and 29.9{\%} for tigecycline, respectively. With the disk diffusion method usingMHagar from BD and Oxoid, susceptibility rates were 82.2{\%} and 72.9{\%} for minocycline and 34.6{\%} and 34.6{\%} for doxycycline, respectively, and rates of MICs of ≤2 μg/ml were 46.7{\%} and 23.4{\%} for tigecycline. In comparison with the standard broth microdilution results, very major rates were low (∼2.8{\%}) for all three drugs across the methods, but major error rates were higher (∼5.6{\%}), especially with the Etest method. For minocycline, minor error rates ranged from 14{\%} to 37.4{\%}. For tigecycline, minor error rates ranged from 6.5{\%} to 69.2{\%}. The majority of minor errors were due to susceptible results being reported as intermediate. For minocycline susceptibility testing of carbapenem-resistant A. baumannii strains, very major errors are rare, but major and minor errors overcalling strains as intermediate or resistant occur frequently with susceptibility testing methods that are feasible in clinical laboratories.",
author = "Peng Wang and Bowler, {Sarah L.} and Kantz, {Serena F.} and Mettus, {Roberta T.} and Yan Guo and McElheny, {Christi L.} and Yohei Doi",
year = "2016",
month = "12",
day = "1",
doi = "10.1128/JCM.01810-16",
language = "English",
volume = "54",
pages = "2937--2941",
journal = "Journal of Clinical Microbiology",
issn = "0095-1137",
publisher = "American Society for Microbiology",
number = "12",

}

Comparison of minocycline susceptibility testing methods for carbapenem-resistant acinetobacter baumannii. / Wang, Peng; Bowler, Sarah L.; Kantz, Serena F.; Mettus, Roberta T.; Guo, Yan; McElheny, Christi L.; Doi, Yohei.

In: Journal of clinical microbiology, Vol. 54, No. 12, 01.12.2016, p. 2937-2941.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Comparison of minocycline susceptibility testing methods for carbapenem-resistant acinetobacter baumannii

AU - Wang, Peng

AU - Bowler, Sarah L.

AU - Kantz, Serena F.

AU - Mettus, Roberta T.

AU - Guo, Yan

AU - McElheny, Christi L.

AU - Doi, Yohei

PY - 2016/12/1

Y1 - 2016/12/1

N2 - Treatment options for infections due to carbapenem-resistant Acinetobacter baumannii are extremely limited. Minocycline is a semisynthetic tetracycline derivative with activity against this pathogen. This study compared susceptibility testing methods that are used in clinical microbiology laboratories (Etest, disk diffusion, and Sensititre broth microdilution methods) for testing of minocycline, tigecycline, and doxycycline against 107 carbapenem-resistant A. baumannii clinical isolates. Susceptibility rates determined with the standard broth microdilution method using cation-adjusted Mueller-Hinton (MH) broth were 77.6% for minocycline and 29% for doxycycline, and 92.5% of isolates had tigecycline MICs of ≤2 μg/ml. UsingMHagar from BD and Oxoid, susceptibility rates determined with the Etest method were 67.3% and 52.3% for minocycline, 21.5% and 18.7% for doxycycline, and 71% and 29.9% for tigecycline, respectively. With the disk diffusion method usingMHagar from BD and Oxoid, susceptibility rates were 82.2% and 72.9% for minocycline and 34.6% and 34.6% for doxycycline, respectively, and rates of MICs of ≤2 μg/ml were 46.7% and 23.4% for tigecycline. In comparison with the standard broth microdilution results, very major rates were low (∼2.8%) for all three drugs across the methods, but major error rates were higher (∼5.6%), especially with the Etest method. For minocycline, minor error rates ranged from 14% to 37.4%. For tigecycline, minor error rates ranged from 6.5% to 69.2%. The majority of minor errors were due to susceptible results being reported as intermediate. For minocycline susceptibility testing of carbapenem-resistant A. baumannii strains, very major errors are rare, but major and minor errors overcalling strains as intermediate or resistant occur frequently with susceptibility testing methods that are feasible in clinical laboratories.

AB - Treatment options for infections due to carbapenem-resistant Acinetobacter baumannii are extremely limited. Minocycline is a semisynthetic tetracycline derivative with activity against this pathogen. This study compared susceptibility testing methods that are used in clinical microbiology laboratories (Etest, disk diffusion, and Sensititre broth microdilution methods) for testing of minocycline, tigecycline, and doxycycline against 107 carbapenem-resistant A. baumannii clinical isolates. Susceptibility rates determined with the standard broth microdilution method using cation-adjusted Mueller-Hinton (MH) broth were 77.6% for minocycline and 29% for doxycycline, and 92.5% of isolates had tigecycline MICs of ≤2 μg/ml. UsingMHagar from BD and Oxoid, susceptibility rates determined with the Etest method were 67.3% and 52.3% for minocycline, 21.5% and 18.7% for doxycycline, and 71% and 29.9% for tigecycline, respectively. With the disk diffusion method usingMHagar from BD and Oxoid, susceptibility rates were 82.2% and 72.9% for minocycline and 34.6% and 34.6% for doxycycline, respectively, and rates of MICs of ≤2 μg/ml were 46.7% and 23.4% for tigecycline. In comparison with the standard broth microdilution results, very major rates were low (∼2.8%) for all three drugs across the methods, but major error rates were higher (∼5.6%), especially with the Etest method. For minocycline, minor error rates ranged from 14% to 37.4%. For tigecycline, minor error rates ranged from 6.5% to 69.2%. The majority of minor errors were due to susceptible results being reported as intermediate. For minocycline susceptibility testing of carbapenem-resistant A. baumannii strains, very major errors are rare, but major and minor errors overcalling strains as intermediate or resistant occur frequently with susceptibility testing methods that are feasible in clinical laboratories.

UR - http://www.scopus.com/inward/record.url?scp=84997707975&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84997707975&partnerID=8YFLogxK

U2 - 10.1128/JCM.01810-16

DO - 10.1128/JCM.01810-16

M3 - Article

C2 - 27629901

AN - SCOPUS:84997707975

VL - 54

SP - 2937

EP - 2941

JO - Journal of Clinical Microbiology

JF - Journal of Clinical Microbiology

SN - 0095-1137

IS - 12

ER -